Related Experiment Video

Updated: Aug 21, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Beyond triple-negative: germline MPL and SH2B3/LNK mutations reshape the genetic landscape of hereditary

Camille Brzechffa1, Angela G Fleischman2

  • 1University of California, Irvine School of Medicine.

Haematologica
|August 20, 2026
PubMed

Abstract:

Not available.

More Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Experiment Videos

Last Updated: Aug 21, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...

Articles linked to this work by shared authors, journal, and citation graph.

Pitavastatin counteracts venetoclax resistance mechanisms including TP53 mutation in acute myeloid leukemia.

Blood neoplasia·2026

Hierarchical tissue structure creates history-dependent barriers to clonal invasion.

bioRxiv : the preprint server for biology·2026

Clonal hematopoiesis-associated DNMT3A mutations derepress bivalent Polycomb target genes and enhance macrophage migration.

bioRxiv : the preprint server for biology·2026

Cigarette smoke and e-cigarette aerosol extracts induce myelopoiesis and suppress inflammatory cytokine production.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

Blood·2026

Real-world evidence for the impact of circadian clock on the benefit from immune checkpoint inhibitors in solid tumors.

BMC cancer·2026

Early measurement of ST2 and REG3α has a prognostic impact in haploidentical transplantation with post-transplant cyclophosphamide.

Haematologica·2026

The double-edged sword of Plasmodium falciparum: malaria and a predisposition to B-cell malignancy?

Haematologica·2026

Venetoclax plus azacitidine in younger adults with acute myeloid leukemia beyond historical comparisons. Comment on: "Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy".

Haematologica·2026

Beyond exclusion: the case for genetic screening in immune thrombocytopenia.

Haematologica·2026

Hyperinflammatory differentiation syndrome with hemophagocytic lymphohistiocytosis-like features following menin inhibition in acute myeloid leukemia.

Haematologica·2026

Neutrophil extracellular traps and DNase I levels in the bronchoalveolar lavage fluid of children with pulmonary injury after allogeneic hematopoietic stem cell transplantation: a TRANSPIRE study.

Haematologica·2026

Left Atrial Undifferentiated Pleomorphic Sarcoma: A Novel HMGA2::AVIL Fusion Presenting as Hemoptysis.

JACC. Case reports·2026

Malignant Hypertension and Thrombotic Microangiopathy Induced by Cocaine Base Paste Use: A Case Report.

Revista medica de Chile·2026

[Advances in the diagnosis and treatment of capillary malformation-arteriovenous malformation syndrome].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026

Still a filtering failure? A follow-up commentary on automated MeSH indexing.

Journal of the Medical Library Association : JMLA·2026

Needle trauma as a trigger for clinical manifestation of a pre-existing venous malformation: a case report.

Journal of surgical case reports·2026

A case report of primary bilateral macronodular adrenal hyperplasia caused by a novel ARMC5 gene variant.

Frontiers in medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us